Angiodynamics (ANGO) Preferred Shares (2012 - 2018)
Angiodynamics' (ANGO) quarterly Preferred Shares came in at $5.0 million in Q3 2018, little changed quarter-over-quarter from $5.0 million in Q1 2013.
Powered by 
Analysis
Angiodynamics (ANGO) Preferred Shares (2012 - 2018) Analysis & Trends
Angiodynamics (ANGO) has reported Preferred Shares for 3 consecutive years, with $5.0 million the latest figure, recorded in Q3 2018.
- For the quarter ending Q3 2018, Preferred Shares changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Aug 2018 stood at $5.0 million (changed N/A YoY), and the FY2013 full-year result was $5.0 million, changed 0.0% from the prior year.
- Preferred Shares was little changed at $5.0 million in Q3 2018 per ANGO's latest filing, from $5.0 million in the prior quarter.
- Across five years, Preferred Shares topped out at $5.0 million in Q3 2018 and bottomed at $5.0 million in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn | - |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn | - |
| 10 | Angiodynamics | 626.21 Mn | 572.35 Mn | 46.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2018 | 5.00 Mn |
| Feb 28, 2013 | 5.00 Mn |
| Nov 30, 2012 | 5.00 Mn |
| May 31, 2012 | 5.00 Mn |